Hong Kong Infrastructure Stock News

Ascletis Pharma (SEHK:1672) just flagged a major pipeline milestone, selecting its in house, AI optimized ASC37 oral triple peptide agonist for clinical development in obesity, with an FDA IND filing targeted for 2026. See our latest analysis for Ascletis Pharma. That R&D breakthrough lands after a wild run in the stock, with a 1 month share price return of 42.97 percent and a massive 1 year total shareholder return of 663.58 percent, suggesting momentum is still very much alive. If this kind...

WuXi Biologics (Cayman) recently announced a Memorandum of Understanding with the Qatar Free Zones Authority to establish its first integrated CRDMO center in the Middle East, extending its global biologics development and manufacturing network into the region. By pairing its one-stop CRDMO capabilities in complex biologics with Qatar’s push to build a regional biotech hub, WuXi Biologics is positioning itself as an early infrastructure partner in shaping the Middle East’s biopharmaceutical...

Inspur Digital Enterprise Technology Limited has completed a follow-on equity offering of HK$493,728,200, issuing 67,634,000 new ordinary shares at HK$7.30 per share with a HK$0.0511 discount per share via a subsequent direct listing. This capital raise expands the company’s funding flexibility while modestly increasing the free float, factors that can reshape how investors view its balance between growth ambitions and ownership dilution. We’ll now examine how this follow-on equity offering,...

China Construction Bank Corporation recently held an Extraordinary General Meeting where shareholders approved a 2025 interim H share cash dividend of RMB 1.858 per 10 shares and endorsed the appointment of Shi Jian as a non-executive director, subject to regulatory approval. The bank is also set to consider a charitable donation to support fire rescue and relief efforts in Hong Kong’s Tai Po District, underlining how capital returns to investors are being balanced with a broader social...

Shanghai Fudan Microelectronics Group (SEHK:1385) just pushed through a sweeping governance revamp at its second EGM, reshaping its Articles of Association, board composition, and committee structure in a bid to streamline oversight. See our latest analysis for Shanghai Fudan Microelectronics Group. Those governance upgrades land at a time when sentiment is already strong, with the latest share price at HK$39.86 and a powerful year to date share price return backing the story, even after a...

China Education Group Holdings Limited has released its full-year results for the year ended August 31, 2025, reporting sales of CNY 7,363 million, up from CNY 6,579 million, and net income of CNY 977 million compared with CNY 418 million a year earlier. The sharp improvement in net income, alongside higher basic earnings per share from continuing operations rising to CNY 0.3551, points to stronger profitability and more efficient operations across the group’s education portfolio. With this...

At its November 25, 2025 extraordinary general meeting, Shanghai MicroPort MedBot (Group) Co., Ltd. approved amendments to its Articles of Association and shareholder meeting rules while reshaping its board and board committees, including appointing Dr. Zhaohua Chang as chairperson and several new non-executive and independent non-executive directors. This governance overhaul, spanning refreshed leadership and reconfigured oversight committees, signals a potential recalibration of how the...

Bank of China (SEHK:3988) has just completed a sizeable RMB 60 billion issue of write down tier 2 bonds. The move is aimed squarely at shoring up capital and giving the balance sheet more strategic flexibility. See our latest analysis for Bank of China. Even with the share price easing 4.65% over the last week, Bank of China still carries a solid year to date share price return of around 16%. Its 1 year total shareholder return north of 30% suggests momentum is still broadly constructive as...

TransThera Sciences (Nanjing) SEHK:2617 has quietly delivered a sharp move over the past 3 months, climbing more than 200%, which naturally raises the question of what the market is now pricing in. See our latest analysis for TransThera Sciences (Nanjing). That surge sits on top of an already extraordinary year to date, with a 726.38% year to date share price return. This suggests investors are rapidly repricing TransThera’s risk and growth prospects, even as near term swings remain...

Following the solid earnings report from Great World Company Holdings Ltd ( HKG:8003 ), the market responded by bidding...

China CBM Group Company Limited ( HKG:8270 ) shares have had a really impressive month, gaining 28% after a shaky...

Despite an already strong run, MMG Limited ( HKG:1208 ) shares have been powering on, with a gain of 27% in the last...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Wisdom Education International Holdings Company Limited ( HKG:6068 ) shareholders that were waiting for something to...

There's no doubt that investing in the stock market is a truly brilliant way to build wealth. But if when you choose to...

Meituan (SEHK:3690) just delivered a mixed third quarter update, with modest revenue growth but a swing from profit to a hefty net loss, right as it launches its new delivery platform, Keeta. See our latest analysis for Meituan. Despite the buzz around Keeta and Meituan’s push into new delivery formats, the 1 year total shareholder return of about -38 percent and steep year to date share price decline suggest sentiment is still cautious rather than momentum driven. If this kind of volatility...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Key Insights Universal Health International Group Holding's Annual General Meeting to take place on 11th of December...

China Infrastructure & Logistics Group Ltd.'s ( HKG:1719 ) price-to-earnings (or "P/E") ratio of 50.1x might make it...

EPI (Holdings) Limited ( HKG:689 ) shares have continued their recent momentum with a 39% gain in the last month alone...

China Literature Limited's ( HKG:772 ) price-to-sales (or "P/S") ratio of 4.7x may look like a poor investment...

Wondering if Lenovo Group is still a smart buy at today’s price, or if the market has already priced in its upside? You are not alone in asking whether the current tag matches its long term potential. The stock has been a bit choppy lately, up 1.4% over the last week but down 12.6% over the past month, even though it is still up 1.2% year to date, 11.2% over 1 year, 81.9% over 3 years, and 109.4% over 5 years. Recent headlines have focused on Lenovo’s push into AI ready PCs, expanding its...

In December 2025, Cirrus Aircraft launched “Cirrus Next,” a trade-in and upgrade program that simplifies purchasing a new Cirrus by offering a streamlined pathway and trade-in option for existing aircraft, covering late-model SR Series and all generations of Vision Jets. By removing the hassle of managing overlapping ownership or downtime without an aircraft, Cirrus Next directly targets a key friction point that can slow upgrade cycles for committed owners. We’ll now examine how this focus...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...